Generex to import insulin spray into Abu Dhabi

Canada's Generex Biotechnology Corp says that the Ministry of Health of the United Arab Emirates' Drugs Control Department has issued a non-objection letter to the Imperial College London Diabetes Centre to import Generex Oral-lyn, its proprietary oral insulin spray product, into Abu Dhabi.

The Manager of the Drugs Control Department indicated that importation of the firm's Oral-lyn can be done via the issuance of a purchase order from the Imperial College London Diabetes Centre to a drug store or pharmacy licensed by the Ministry.

The Imperial College Centre is part of the government-supported Zayed Military Hospital, which treats an estimated total of 5,000 patients. Anna Gluskin, chief executive of Generex, said: "this step is significant in that it allows the company to introduce Oral-lyn into the Middle East via an established organization with a strong diabetes treatment program. We anticipate that this model will serve the purpose of demonstrating the product's safety and efficacy to other health agencies within the Middle East."